Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 9/20 | 0.38 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | FNTA | P49354 | 3/20 | 0.37 |
| ▸ | FNTB | P49356 | 3/20 | 0.37 |
| ▸ | ACHE | P22303 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.35 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 1/20 | 0.35 |
| ▸ | HTR6 | P50406 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4343072 | 0.79 | NOX1 (0.39) | BCHENOX1MEN1LMNAKMT2A | |
| Phosphoric Acid SCHEMBL6395405 | 0.78 | MEN1 (0.48) | BCHENOX1MEN1LMNAKMT2A | |
| SCHEMBL4080875 | 0.75 | MEN1 (0.52) | BCHENOX1MEN1LMNAKMT2A | |
| SCHEMBL4080952 | 0.73 | BCHE (0.40) | BCHENOX1LMNAFNTAFNTB | |
| SCHEMBL4088094 | 0.71 | NOX1 (0.42) | BCHENOX1MEN1LMNAKMT2A | |
| SCHEMBL5073280 | 0.71 | BCHE (0.40) | BCHENOX1ACHEMAPT | |
| SCHEMBL7617079 | 0.68 | BCHE (0.42) | BCHENOX1MEN1LMNAKMT2A | |
| SCHEMBL4080999 | 0.67 | NOX1 (0.40) | BCHENOX1MEN1LMNAKMT2A | |
| SCHEMBL7026702 | 0.67 | MEN1 (0.38) | BCHENOX1MEN1LMNAKMT2A | |
| SCHEMBL2496191 | 0.66 | BCHE (0.38) | BCHENOX1FNTAFNTBACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7358358-B2 | Electrochromic compound | NTERA LIMITED (IE) | 2008-04-15 | — | — | US | claimed |
| US-7270880-B2 | Electrochromic particles | NTERA LIMITED (IE) | 2007-09-18 | — | — | US | claimed |
| US-7253940-B2 | Nanoporous and nanocrystalline film and electrochromic device | UNIVERSITY COLLEGE DUBLIN, A CONSTITUENT COLLEGE OF THE NATIONAL UNIVERSITY OF IRELAND (IE) | 2007-08-07 | — | — | US | claimed |
| JP-3934420-B2 | — | — | 2007-06-20 | — | — | JP | claimed |
| US-20060097233-A1 | Electrochromic particles | NTERA LIMITED (IE) | 2006-05-11 | — | — | US | claimed |
| EP-1592758-A1 | ELECTROCHROMIC PARTICLES | Ntera Limited (IE) | 2005-11-09 | — | — | EP | claimed |
| US-20050128561-A1 | Electrochromic compound | UNIVERSITY COLLEGE DUBLIN, A CONSTITUENT COLLEGE OF THE NATIONAL UNIVERSITY OF IRELAND | 2005-06-16 | — | — | US | claimed |
| US-20050128562-A1 | Nanoporous and nanocrystalline film and electrochromic device | UNIVERSITY COLLEGE DUBLIN, A CONSTITUENT COLLEGE OF THE NATIONAL UNIVERSITY OF IRELAND | 2005-06-16 | — | — | US | claimed |
| EP-1500969-A1 | Compound and its use in electrochromic devices | UNIVERSITY COLLEGE DUBLIN (IE) | 2005-01-26 | — | — | EP | claimed |
| EP-1224505-B1 | ELECTROCHROMIC DEVICE | UNIV DUBLIN (IE) | 2005-01-12 | — | — | EP | claimed |
| WO-2004067672-A1 | ELECTROCHROMIC PARTICLES | NTERA LIMITED (IE) | 2004-08-12 | — | — | WO | claimed |
| EP-1443090-A1 | Electrochromic particles | Ntera Limited (IE) | 2004-08-04 | — | — | EP | claimed |
| JP-2003511837-A | — | — | 2003-03-25 | — | — | JP | claimed |
| EP-1224505-A1 | ELECTROCHROMIC DEVICE | UNIVERSITY COLLEGE DUBLIN (IE) | 2002-07-24 | — | — | EP | claimed |
| WO-2001027690-A2 | ELECTROCHROMIC DEVICE | UNIVERSITY COLLEGE DUBLIN (IE) | 2001-04-19 | — | — | WO | claimed |
| US-7576201-B2 | Electrochromic compound | NTERA LIMITED (IE) | 2009-08-18 | — | — | US | disclosed |
| US-20080167465-A1 | Electrochromic compound | FITZMAURICE DONALD | 2008-07-10 | — | — | US | disclosed |
| EP-1443090-A1 | Electrochromic particles | Ntera Limited (IE) | 2004-08-04 | — | — | EP | disclosed |
| EP-1224505-A1 | ELECTROCHROMIC DEVICE | UNIVERSITY COLLEGE DUBLIN (IE) | 2002-07-24 | — | — | EP | disclosed |
| WO-2001027690-A2 | ELECTROCHROMIC DEVICE | UNIVERSITY COLLEGE DUBLIN (IE) | 2001-04-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080167465-A1 | Electrochromic compound | KCNH2, PRDM9, H1-10 | BCHE 1722/4885NOX1 2876/4885MEN1 3335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.